FDA official logo
GSRS logo
PFDA official logo

HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

  • UNII: Z845VHQ61P
  • Preferred Substance Name: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

  • GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
  • GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
  • GARDASIL-9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
  • HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION
  • HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
  • HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
  • HUMAN PAPILLOMAVIRUS TYPE 11 CAPSID PROTEIN ANTIGEN, A
  • HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
  • RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
  • SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo